Unknown

Dataset Information

Neural mechanisms of expectancy-based placebo effects in antidepressant clinical trials.


ABSTRACT:

Background

Patient expectancy of therapeutic improvement is a primary mediator of placebo effects in antidepressant clinical trials, but its mechanisms are poorly understood. This study employed a novel antidepressant trial design, with integrated functional magnetic resonance imaging (fMRI), to manipulate patient outcome expectancy and examine its neural mediators.

Method

Twenty-three depressed outpatients, in a randomized controlled trial were assigned to either Open (high outcome expectancy) or Placebo-controlled (low outcome expectancy) treatment with citalopram for eight weeks. fMRI scans were acquired before and after the expectancy manipulation (before medication treatment), while participants performed a masked emotional face task. Focusing on an amygdala region-of-i

SUBMITTER: Zilcha-Mano S 

PROVIDER: S-EPMC6790474 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature